|
Zhuhai Homology2019Annual National Medical Insurance Catalogue |
|
Drug Classification |
Types of Medicare |
Number |
Name of drug |
Dosage form |
Remarks |
|
Cough and cold preparations |
nail |
1137 |
ambroxol |
Oral sustained-release formulations |
|
|
β-Receptor blockers |
nail |
367 |
metoprolol |
Oral sustained-release formulations |
|
|
Systemic antibiotics |
nail |
647 |
Azithromycin |
Oral sustained-release formulations |
|
|
Drugs for gastric acid-related diseases |
nail |
14 |
Ranitidine |
Oral sustained-release formulations |
|
|
Systemic antibiotics |
nail |
659 |
Levofloxacin |
Oral sustained-release formulations |
|
|
Blood substitutes and perfusates |
nail |
277 |
Glycerol fructose sodium chloride |
injection |
|
|
Mineral supplements |
B |
177 |
Calcium carbonate |
Oral sustained-release formulations |
|
|
Systemic antibiotics |
B |
651 |
Roxithromycin id |
Oral sustained-release formulations |
|
|
Blood substitutes and perfusates |
B |
284 |
Alanyl glutamine |
injection |
Limited patients with fasting doctor's advice, and in accordance with the general rules for enteral and parenteral nutrition preparations |
|
Blood substitutes and perfusates |
B |
275 |
Sterilized water for injection |
injection |
|
|
Vitamins |
B |
162 |
Water-soluble vitamins |
injection |
Payment is limited to the use of parenteral nutrition drugs such as fat emulsion and amino acids, but not to the use alone. |
|
Drugs for peptic ulcer and gastroesophageal reflux disease |
B |
★(15) |
omeprazole |
injection |
Patients with limited disease diagnosis and fasting or dysphagia as indicated in the instructions |
|
Systemic antiviral drugs |
B |
★(710) |
Ganciclovir |
injection |
|
|
Gallbladder and Liver Therapeutic Drugs |
B |
★(52) |
Diammonium glycyrrhizinate |
injection |
Limited liver failure or inability to use oral glycyrrhizic acid preparations |
|
Systemic antibiotics |
B |
★(659) |
Levofloxacin sodium chloride |
injection |
|